Answers are grounded in this paper and cite their sources.
Cytotoxic activity of new coumarin compounds shows growth inhibition in human cancer cells, highlighting their potential as anticancer agents.
One of the biggest causes of death around the world is cancer. Despite the development of a variety of chemotherapeutic drugs that stop excessive cell division, drug resistance remains a major obstacle to chemotherapy. It is consequently critical to develop and find new and effective anti-cancer agents in order to address the global threat. Owing to coumarins are a promising scaffold for anticancer agents, in this approach, we interested to synthesis new coumarins linked to either 1,3-thiazols or 1,3,4-thiadiazoles and examined their cytotoxic efficacy. Eleven of the newly prepared compounds were selected for the in vitro anticancer investigations against 60 human cancer cell lines at a single dose (10- 5M). Based on the results, we observed that compounds 3a, 3b, 6, 8a, b and 10b were the most active towards different cancer cell lines where the growth inhibition percent (GIP) was up to 96%. Moreover, compound 6 had lethality effect against melanoma MDA-MB-435 and renal cancer A498 with growth percent - 47.47 and - 6.20. Also, the lethal effects were seen with compound 10b where it exerted a value of - 27.79% toward melanoma MDA-MB-435.The highest GIP values 96.03% was recorded for compound 10a against melanoma MDA-MB-435 cancer cell line.
No takes yet. Share an insight, caveat, or question.
Abdel‐Aziem et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: